Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W O Bechstein

Showing results (281-290 of 351) with videos related to

Pageof 36
Sort By:
Transplantation Proceedings|February 1, 1995
Interleukin-2 receptor antibody vs ATG for induction immunosuppression after liver transplantation: initial results of a prospective randomized trialH P Lemmens, J M Langrehr, W O Bechstein, et al.
Transplantation Proceedings|December 1, 1996
Long-term follow-up in hepatitis C patients with respect to immunosuppressionA R Mueller, K P Platz, T Berg, et al.
Transplantation|June 1, 1993
Comparison of quadruple immunosuppression after liver transplantation with ATG or IL-2 receptor antibodyP Neuhaus, W O Bechstein, G Blumhardt, et al.
Transplantation Proceedings|December 1, 1996
Does the choice of primary immunosuppression influence the prevalence of cardiovascular risk factors after liver transplantation?O Guckelberger, J M Langrehr, W O Bechstein, et al.
Transplantation Proceedings|March 20, 1999
Mycophenolate mofetil in combination with tacrolimus versus Neoral after liver transplantationJ Klupp, M Glanemann, W O Bechstein, et al.
Transplantation Proceedings|March 20, 1999
Contribution of donor age and ischemic injury in chronic renal allograft dysfunctionS G Tullius, A Reutzel-Selke, M Nieminen-Kelhä, et al.
Transplantation|October 27, 1996
A new oral formulation of cyclosporine for early oral immunosuppressive therapy in liver transplant recipientsM Winkler, G Haller, K Oldhafer, et al.
Transplantation Proceedings|November 20, 1997
A second native renal allograft of donor origin in a model of chronic rejection demonstrates improved long-term functionS G Tullius, M Nieminen, W O Bechstein, et al.
Transplantation Proceedings|February 1, 1993
Quadruple induction immunosuppression after liver transplantation with IL-2 receptor antibody (BT 563) is equally effective and better tolerated than ATG induction therapyB Neuhaus, H Keck, W O Bechstein, et al.
Fortschritte Der Medizin|March 30, 1993
[Liver transplantation as a routine procedure? Indications and results in 270 patients]J M Langrehr, G Blumhardt, W O Bechstein, et al.
Pageof 36

Showing results (281-290 of 351) with videos related to

Sort By:
Pageof 36
Transplantation Proceedings|February 1, 1995
Interleukin-2 receptor antibody vs ATG for induction immunosuppression after liver transplantation: initial results of a prospective randomized trialH P Lemmens, J M Langrehr, W O Bechstein, et al.
Transplantation Proceedings|December 1, 1996
Long-term follow-up in hepatitis C patients with respect to immunosuppressionA R Mueller, K P Platz, T Berg, et al.
Transplantation|June 1, 1993
Comparison of quadruple immunosuppression after liver transplantation with ATG or IL-2 receptor antibodyP Neuhaus, W O Bechstein, G Blumhardt, et al.
Transplantation Proceedings|December 1, 1996
Does the choice of primary immunosuppression influence the prevalence of cardiovascular risk factors after liver transplantation?O Guckelberger, J M Langrehr, W O Bechstein, et al.
Transplantation Proceedings|March 20, 1999
Mycophenolate mofetil in combination with tacrolimus versus Neoral after liver transplantationJ Klupp, M Glanemann, W O Bechstein, et al.
Transplantation Proceedings|March 20, 1999
Contribution of donor age and ischemic injury in chronic renal allograft dysfunctionS G Tullius, A Reutzel-Selke, M Nieminen-Kelhä, et al.
Transplantation|October 27, 1996
A new oral formulation of cyclosporine for early oral immunosuppressive therapy in liver transplant recipientsM Winkler, G Haller, K Oldhafer, et al.
Transplantation Proceedings|November 20, 1997
A second native renal allograft of donor origin in a model of chronic rejection demonstrates improved long-term functionS G Tullius, M Nieminen, W O Bechstein, et al.
Transplantation Proceedings|February 1, 1993
Quadruple induction immunosuppression after liver transplantation with IL-2 receptor antibody (BT 563) is equally effective and better tolerated than ATG induction therapyB Neuhaus, H Keck, W O Bechstein, et al.
Fortschritte Der Medizin|March 30, 1993
[Liver transplantation as a routine procedure? Indications and results in 270 patients]J M Langrehr, G Blumhardt, W O Bechstein, et al.
Pageof 36